ASX/RCE (ASX/RCE)

Australian Securities Exchange: ASX/RCE · AUD

A$0.36

+0.03 (+9.1%)· Recorded snapshot

Market cap	110.1M
Revenue (ttm)	9.5M
Net income (ttm)	-15M
EPS (ttm)	-A$0.05
Shares out	305.8M
Volume	10,314,707
Beta	0.54

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 9.5M
Net income (ttm): -15M
EPS (ttm): -A$0.05
Market cap: 110.1M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/En/a

P25 14.6P50 21P75 31.9

Trailing P/En/a

P25 15.4P50 29.4P75 64.4

ROEn/a

P25 -108P50 -50.6P75 1.1

ROIC-1,207.8

P25 -64.5P50 -33.5P75 0.8

Benchmarks · 1M

All ASX/RCE indicators

Market & fundamental data

Available fields

173

Groups with data

Currency

AUD

Showing 173 of 173 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-09-04
Enterprise value	AUD 117.6M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2007
Industry	Biotechnology
Is primary listing	Yes
ISIN number	AU000000RCE5
Last earnings date	2026-02-26
Last refreshed	2026-10-30
Market cap	AUD 110.1M
Price	AUD 0.36
Price currency	AUD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-30
Symbol	asx/RCE
Website	https://www.recce.com.au

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-14.37%
EV/Sales	12.42x
FCF / EV yield	-8.46%
FCF yield	-9.04%
Industry forward P/E	28.82x
P/S ratio	11.63x
Sector forward P/E	34.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-146.46%
EBITDA margin	-145.73%
Gross margin	13.11%
Operating margin	-146.46%
Pretax margin	-158.06%
Profit margin	-158.06%
Profitable quarters	1
ROA	-82.75%
ROA (5Y)	-119.56%
ROCE	177.87%
ROIC	-1,207.75%
SBC / revenue	11.26%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	2
Net income growth quarters	1
Net income growth years	1
Revenue growth	26.06%
Revenue growth (Q)	1,509.48%
Revenue growth (QoQ)	2,097.28%
Revenue growth 10Y	48.87%
Revenue growth 3Y	29.43%
Revenue growth 5Y	42.04%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	AUD -61,967
Depreciation and amortization	AUD 69,153
EBIT	AUD -13.9M
EBITDA	AUD -13.8M
EPS	AUD -0.05
FCF per share	AUD -0.03
Financing cash flow	AUD 2M
Free cash flow	AUD -10M
Free cash flow minus SBC	AUD -11M
Gross profit	AUD 1.2M
Investing cash flow	AUD 123,597
Net borrowing	AUD -1.7M
Net cash flow	AUD -7.8M
Net income	AUD -15M
Operating cash flow minus SBC	AUD -11M
Operating income	AUD -13.9M
Revenue	AUD 9.5M
Stock-based compensation	AUD 1.1M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-18.87
Book value per share	AUD -0.06
Interest coverage	-8.67
Long-term assets	AUD 1.4M
Long-term liabilities	AUD 8.9M
Net cash (debt)	AUD -7.5M
Net cash / market cap	-6.82%
Piotroski F-Score	4
Property, plant and equipment	AUD 1.4M
Shareholders' equity	AUD -16.7M
Tangible book value	AUD -16.7M
Tangible book value per share	AUD -0.06
Total assets	AUD 8.5M
Total cash	AUD 2.9M
Total debt	AUD 10.4M
Total liabilities	AUD 25.3M
WACC	7.64%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.9
Current assets	AUD 7.1M
Current liabilities	AUD 16.3M
Current ratio	0.44
Net working capital	AUD -10.4M
Quick ratio	0.4
Working capital	AUD -9.2M
Working capital turnover	-4.79

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-22.02%
Shareholder yield	-22.02%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	105.71%
10Y return CAGR	7.69%
10Y total return	109.77%
150-day SMA	AUD 0.41
1D price change	9.09%
1M price change	10.77%
1M total return	10.77%
1W price change	7.46%
1W total return	7.46%
1Y price change	-10%
1Y return CAGR	-10.01%
1Y total return	-10%
20-day SMA	AUD 0.31
200-day SMA	AUD 0.45
3M price change	-1.37%
3M total return	-1.37%
3Y price change	-20%
3Y return CAGR	-6.87%
3Y total return	-19.23%
50-day SMA	AUD 0.33
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 0.73
52-week high date	2026-01-15
52-week low	AUD 0.27
52-week low date	2026-10-13
5Y price change	-62.5%
5Y return CAGR	-17.49%
5Y total return	-61.76%
6M price change	-31.43%
6M total return	-31.43%
All-time high	AUD 1.88
All-time high date	2020-09-08
All-time low	AUD 0.13
All-time low date	2019-02-08
Average true range (ATR)	AUD 0.02
Average volume	674.2K
Beta (1Y)	1.28
Beta (2Y)	1.17
Beta (5Y)	0.54
Change from 52-week high	-50.68%
Change from 52-week low	35.85%
Change from all-time high	-80.8%
Change from all-time low	176.92%
Change from open	4.35%
Day's gap	4.55%
Dollar volume	AUD 3.7M
High price	AUD 0.37
Low price	AUD 0.35
Monthly RSI	44.06
Open price	AUD 0.35
Position in 52-week range	75%
Previous close	AUD 0.33
Price vs 150-day SMA	-12.58%
Price vs 20-day SMA	15.27%
Price vs 200-day SMA	-19.37%
Price vs 50-day SMA	7.82%
Relative volume	64.03
RSI	59.94
Sharpe ratio	0.07
Sharpe ratio (3Y)	0.13
Sharpe ratio (5Y)	-0.04
Sortino ratio	0.19
Sortino ratio (3Y)	0.3
Sortino ratio (5Y)	0.04
Volume	10.3M
Weekly RSI	45.15
YTD price change	-44.62%
YTD total return	-44.62%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	219.8M
Shares change (QoQ)	0.02%
Shares change (YoY)	22.02%
Shares held by insiders	19.81%
Shares held by institutions	14.33%
Shares outstanding	305.8M

Deeper analysis on ASX/RCE

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/RCE report

Is a complete ASX/RCE research report available?

No complete published report is available for asx/RCE (ASX/RCE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/RCE (ASX/RCE)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/RCE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/RCE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/RCE

Frequently asked questions